Novartis s Transparency Corporate Social Responsibility

Novartis’s Transparency Corporate Social Responsibility (CSR) Ben Lawton, Erin Shull Sean Avjian, Zain Ali Clark University Author Note This paper was prepared for MGMT 170 Managerial Communication taught by Professor Cheryl Amantea in the Fall Semester Novartis’s Transparency Corporate Social Responsibility (CSR) Introduction to Corporate Social Responsibility (CSR) Corporate Social Responsibility (CSR) is a measure of a business’s impacts on society, both positive and negative. Pharmaceutical companies in particular are held to a high ethical standard by the public due to the nature of their products. Novartis, the third largest drug and biotech company in the world, aspires to be a model of ethics and philanthropy in the industry. The company uses its size and global prominence to set a high CSR standard for all businesses. This paper examines some of Novartis’s most recent projects that contribute to the company’s respected reputation, but also investigates lawsuits against Novartis and shortcomings with its transparency, both of which the administration continually fails to address. Recent Philanthropic Initiatives Novartis has increased its budget for charitable healthcare over the last few years. The company developed entire departments to oversee charity projects, raise awareness of diseases, and increase accessibility to its products. These projects focus on providing both preventative and treatment-based healthcare to low-income populations. WorkShow MoreRelatedCorporate Social Responsibility ( Csr )1226 Words   |  5 PagesNovartis’ Transparency Corporate Social Responsibility (CSR) Introduction to Corporate Social Responsibility (CSR) Consumers all over the world are pressuring companies to become more socially responsible. Corporate Social Responsibility (CSR) is a measurement of a business’ impacts on society, both positive and negative. Pharmaceutical companies in particular are held to a high ethical standard by the public due to the nature of their product. Novartis, one of the largest healthcare and pharmaceuticalRead MoreJohnson Johnson Financial Analysis4755 Words   |  20 Pagesincludes the Johnsons baby care line, the Neutrogena skin and hair care line, o.b. and Stayfree feminine hygiene products, the Reach oral care line, Band-Aid brand adhesive bandages, Imodium A-D diarrhea treatment, Mylanta gastrointestinal product s, Pepcid AC acid controller, Tylenol, Motrin, and St. Joseph pain relievers, and Benecol and Splenda sweeteners. Jamp;J generates about 40 percent of its revenues outside the United States, through its network of 200 operating companies in 57 countriesRead MoreCsr Communication in the Pharma Industry35538 Words   |  143 PagesNielsen MA in Corporate Communication Ã…rhus, Denmark. August 2010 CSR COMMUNICATION IN THE PHARMACEUTICAL INDUSTRY Josà © Javier Levrino Table of contents Abstract 1. Introduction 1.1 Motivation 1.2 Problem statement 1.3 Delimitation 1.4 Methodology 1.4.1 1.4.2 1.4.3 1.4.4 Scientific paradigm: hermeneutics Qualitative research approach Theoretical framework Analysis of websites 1.4.4.1 Selection criteria 1.4.4.2 Data collection 1.5 Structure 2. Theoretical framework 2.1. Corporate CommunicationRead MoreGlobal Pharmaceutical Industry Analysis7049 Words   |  29 Pagesgenerics emerged. The top 10 firms and their particulars are provided in the table below. Rank 2008 Company Country Total Revenues(USD millions) Healthcare RD 2006(USD millions) Net income/ (loss) 2006(USD millions) Employees 2006 1 Novartis Switzerland 53,324 7,125 11,053 138,000 2 Pfizer USA 48,371 7,599 19,337 122,200 3 Bayer Germany 44,200 1,791 6,450 106,200 4 GlaxoSmithKline United Kingdom 42,813 6,373 10,135 106,000 5 Johnson and Johnson USA 37,020 5,349 7,202 102,695 Read MoreJohnson and Johnson Analysis9749 Words   |  39 Pagessegment reported an increase in sales from 2008. This segment increased its sales by 1.9 percent from 2008’s figures to $23.6B. The Pharmaceuticals segment reported sales of $22.5B (down 8.3 percent), while the Consumer Products segment reported sales of $15.8B (down 1.6 percent) (JNJ 2009 Annual Report). Only the Medical Devices and Diagnostics US sales showed any increase from 2008’s sales levels. Figure 1 below represents the three business segments displaying US and International 2009 salesRead MorePharmaceutical Industry Ethical Practices13569 Words   |  55 Pages| Ethics in Corporate Society | | PHARMACEUTICAL MARKETING-the growing ethical concern? Analytical Report | | | Madiha Raza Noama Naeem Sheikh Zargham Zaigham LETTER OF AUTHORIZATION November 5, 2011 Dear Readers, As students of BBA, our course instructor of Ethics in Corporate Society, Ms. Tania Danish authorized us to make a report on the â€Å"PHARMACEUTICAL MARKETING-the growing ethical concern?† We were required to make a report in accordance to our learning in the courseRead MoreProblems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability14741 Words   |  59 Pagesrationale around that $68 billion deal: That Wyeth s products will make up for Lipitor s fall off the patent cliff. Many big Pharma companies have responded to the current business climate by engaging in a variety of strategies aimed at paving the way for future success. Examples of this are, Merck s recent merger with Schering Plough, a move aimed at consolidation based on perceived pipeline synergies, the Pfizer buyout of Wyeth and Roche s acquisition of Genentech. Others have pursued the pathRead MoreMarketing Project of Reckitt Benckiser19417 Words   |  78 PagesBusiness Week 50, the magazines annual ranking of the best performing companies within the Samp;P European 350.The companys strategy is to have a highly focused portfolio concentrating on its 17 most profitable brands, which were responsible for 62% of net revenues in 2008. 35% of net revenues come from products launched in the past three years, this focus on innovation was recognized by The Economist Corporate Use of Innovation Award in 2009.The company held Platinum status in 2005, 2006, 2007 andRead MoreThe Mind of a Marketing Manager26114 Words   |  105 Pages William Rothschild Ultimately, we wanted Nike to be the world s best sports and fitness company. Once you say that, you have a focus. You don t end up making wing tips or sponsoring the next Rolling Stones world tour. Phil Knight Most business strategies are inadequate for today s markets. They lack context and differenc flexibility and engagement. They often miss the bigger opportunities, andRead MoreMarketing Project of Reckitt Benckiser19403 Words   |  78 PagesBusiness Week 50, the magazines annual ranking of the best performing companies within the Samp;P European 350.The companys strategy is to have a highly focused portfolio concentrating on its 17 most profitable brands, which were responsible for 62% of net revenues in 2008. 35% of net revenues come from products launched in the past three years, this focus on innovation was recognized by The Economist Corporate Use of Innovation Award in 2009.The company held Platinum status in 2005, 2006, 2007 and